Susquehanna International Group, LLP Chimerix Inc Put Options Transaction History

Susquehanna International Group, LLP

  • $527 Billion
  • Q2 2024

Put Options

5 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 15, 2024
BUY
$0.87 - $1.05 $63,597 - $76,755
73,100 Added 214.37%
107,200 $94,000
Q1 2024

May 07, 2024
BUY
$0.91 - $1.26 $31,031 - $42,966
34,100 New
34,100 $36,000
Q3 2023

Nov 14, 2023
BUY
$0.94 - $1.23 $18,800 - $24,600
20,000 New
20,000 $19,000
Q4 2022

Feb 14, 2023
SELL
$1.67 - $2.35 $47,261 - $66,505
-28,300 Reduced 71.28%
11,400 $21,000
Q3 2022

Nov 14, 2022
BUY
$1.81 - $2.76 $36,019 - $54,923
19,900 Added 100.51%
39,700 $77,000

Others Institutions Holding CMRX

# of Institutions
81
Shares Held
36.8M
Call Options Held
72.2K
Put Options Held
169K
View Full List

About CHIMERIX INC

CMRX Quotes by TradingView
  • Ticker CMRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,622,896
  • Market Cap $85M
  • Description
  • Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...
More about CMRX
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email